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1. Introduction 
The mouse hybridoma ntibody termed anti- 
SSEA-1 recognises a differentiation antigen which 
appears at the 8-cell stage of mouse embryos and 
becomes restricted to only certain cells in differenti- 
ated tissues [1]. In [2] anti-SSEA-1 bound to a glyco- 
protein-rich extract of human meconium. This bind- 
ing formed the basis of a radioimmunoassay which 
was used to investigate the antigenic determinant 
recognised by the antibody. Inhibition assays with 
glycoproteins ofknown blood group activities and 
with a variety of natural and chemically synthesized 
oligosaccharides showed that this antigenic deter- 
minant involves a fucosylated structure distinct from 
blood group H. 
Among the oligosaccharides t sted as inhibitors of 
anti-SSEA-1 the most potent was one derived from a 
partially degraded ovarian cyst glycoprotein [3] and 
designated N-1 R L 0.71a: 
II which have been extensively purified by column 
and paper chromatographies areknown [4] to con- 
tain varying amounts of the isomeric structure lacto- 
N-fucopentaose III (LNFP III). LNFP II and LNFP III 
differ in having type 1 (Gal~l -> 3GlcNAc) or type 2 
(Gal/31 -+ 4GlcNAc)-based non-reducing terminal 
sequences, respectively. It was important to deter- 
mine whether the inhibitory activity observed with 
the type 1, Lea-active oligosaccharides represents a 
cross-reaction r whether it is due to the presence of 
type 2 isomers in the preparations tested. 
LNFP II and LNFP III can be separated by thin- 
layer chromatography (TLC) of acetylated derivatives 
[5]. Here, the purified isomers have been tested as 
inhibitors of anti-SSEA-1 in radioimmunoassays nd 
it has been established that this antibody is specific 
for the type 2 sequence. 
2. Materials and methods 
Gal/31 -+ 4GlcNAc/31 -+ 6 (?)-3hexenetetrol 
I" 1,3 
Fuca 
However, preparations of the milk oligosaccharides 
lacto-N-fucopentaose II (LNFP II) and lacto-N- 
difucohexaose II which have the Lea-active, terminal 
non-reducing sequence: 
Gal/31 -+ 3GlcNAc/31 ~ (from [4]) 
1" 1,4 
Fuca 
were also inhibitory being ~10-times less active than 
oligosaccharide N-1 R L 0.71 a. Preparations of LNFP 
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2.1. Materials 
LNFP preparations [6] kindly provided by Dr 
W. M. Watkins of this Institute were reduced [7] in 
the presence of tritiated sodium borohydride 
(Amersham International, Amersham). The anti- 
SSEA-1 reagent [1 ] was ascites fluid from a pristane- 
primed BALB/c mouse injected with antibody- 
producing hybrid cells and was kindly provided by 
Drs D. Solter and B. B. Knowles, Wistar Institute of 
Anatomy (Philadelphia PA). 
2.2. Radioimmunoassays 
The reactivities of oligosaccharides with anti- 
SSEA-1 were assayed in a double antibody radio- 
immunoassay s in [2]. In brief, serial dilutions of 
oligosaccharides were used as inhibitors of the bind- 
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ing of anti-SSEA-1 ascites fluid (1/3000 dilution) to 
a radioiodinated glycoprotein extract of human 
meconium which had been enriched for blood group I, 
i and SSEA-1 activities by affinity chromatography 
on an anti-I immunoadsorbent column. 
2.3. Thin-layer chromatography 
TLC of oligosaccharides was performed on Whatman 
HPK silica gel plates (5/~m) either as non-derivatised 
samples in solvent system n-butanol/acetone~water 
(12:10:8, by vol.) or as reduced and acetylated [5] 
derivatives in solvent system butyl acetate/acetone/ 
water (25:8:1, by vol.). For preparative TLC H100 gg 
reduced, tritiated and acetylated oligosaccharide was 
loaded/5 cm plate. Sugar components, located using 
a Packard 7222 series radiochromatogram scanner 
(Packard Instrument Co., Downers Grove IL) were 
eluted with 10% water in acetone, dried and de-acet- 
ylated [5]. In analytical runs sugars were located with 
0.5% orcinol in 1 M sulphuric acid spray. Stachyose 
(Sigma London Chemical Co., Poole) was used as a 
standard oligosaccharide. Lacto-N-tetraose and lacto- 
N-neotetraose were kindly provided by Dr W. M. 
Watkins of this Institute. 
2.4. Monosaccharide analyses 
Monosaccharide analyses were performed by gas 
liquid chromatography of trimethylsilyl ethers of 
methyl glycosides [8] on a column (2100 X 0.4 cm) 
of 3% OV1 on chromosorb WHP (Chromatography 
Services, Hoylake, Merseyside) with i-inositol (Sigma) 
as internal standard and using a Pye Unicam (Pye 
Unicam, Cambridge) series 204 chromatograph with 
intergration by a Columbia Scientific Industries' 
Supergrator (Kemtronix UK, Compton, Berkshire). 
3. Results and discussion 
Two preparations of LNFP II were found to have 
differing inhibitory activities in radioimmunoassays 
with anti-SSEA-1, being ~10- (preparation 1) and 40- 
(preparation 2) times less active on a molar basis than 
oligosaccharide N-1 R L 0.71a (fig.l). 
TLC of reduced and acetylated erivatives showed 
that both preparations contained more than one com- 
ponent (fig.2). Two of these had mobilities consistent 
with them being the isomers LNFP II and LNFP I l l  
(R F 0.25 and 0.33, respectively in agreement with Dr 
S. Hakomori, personal communication). A third com- 
ponent ermed band IV (R E 0.56) was unidentified. 
All three components were shown by GLC (after 
purification by TLC and de-acetylation) to have the 
carbohydrate composition of reduced lacto-N-fuco- 
pentaose isomers (galactose/fucose/N-acetylglucos- 
amine/glucitol, 2.0:1.1 0.8:0.8:1.1-0.9).  
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Fig.1. Inhibition by oligosaccharides of the binding of anti- 
SSEA- 1 to 12s I-labelled meconium glycopro teins. The symbols 
used, the designations and the structures of the oligosae- 
chaxides axe: 
(*) oligosaccharide N-I R L 0.71a 
Gall31 -~ 4GlcNAcl31 --+ 6(?)-3hexenetetrol 
113 
t~ 'uc~ ' 
(o) lacto-N-fucopentaose III (LNFP IIl) 
Ga1431 -+ 4GlcNAct31 -~ 3Gal/31 ~ 4Glc 
i" 1,3 
Fuca 
(0) lacto-N-fucopentaose II (LNFP II) 
Gal/31 -+ 3GlcNAcl31 ~ 3GalCH -~ 4Glc 
1,4 
Fuca 
(o) band IV; t~,~) preparations 1 and 2, respectively of lacto- 
N-fucopentaose II before fractionation. The inhibition data 
for N-1 R L 0.71a and preparation 1 ( - - )  have been taken 
from [2]. 
The differences in the activities of N-1 R L 0.7 la and LNFP 
III axe probably not due to experimental error. Although the 
inhibition data were taken from two different assays there is 
little assay-to-assay variation. The other possible source of 
error, that of the quantitation of small amounts of oligosac- 
chaxides, was also not apparent. Inhibitor concentrations 
determined by hexose analysis ([11 ] using galactose as stan- 
daxd) and GLC were in agreement with each other and with 
those calculated from the dry weight where available (N-1 
R L 0.71a and LNFP II preparation 2 before fractionation). 
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Fig.2. Thin-layer chromatography of reduced, tritiated and acetylated oligosaccharides. Scans 1 and 2 are radiochromatograms of 
LNFP preparations 1 and 2, respectively. Lanes A -H  are otigosaccharides r vealed by charring with orcinol/sulphuric a id. The 
lanes are taken from 3 separate chromatograms as follows: (A,B); (C,F,G); (D,E,H). Lanes (A,H) are stachyose (neutral tetrasac- 
charide); lane (B) corresponds to scan 2; lanes (C,E-G) are preparative TLC products of LNFP preparation 2. The products in 





A B C D E F 
Fig.3. Thin-layer chromatography of non-derivatised (A,E,F) 
and reduced, purified oligosaccharides after de-acetylation 
(B,C,D): lane (A) stachyose (with a minor contaminant); 
lane (E), lacto-N-tetraose; lane (F) lacto-N-neotetraose; lane 
(B) band IV; lane (C) LNFP III; lane (D) LNFP II. 
The product identified as LNFP III was the major 
component in preparation t, which had the greatest 
inhibitory activity in the radioimmunoassay (fig.2, 
scan 1). Preparation 2 (scan 2) had a smaller propor- 
tion of this isomer. This latter preparation was frac- 
tionated by preparative TLC as illustrated in fig.2 
(B-G). The two slowest migrating components shown 
in lane B were identified as partially acetylated oligo- 
saccharides as, for example, the products in lane C 
were converted into the products in lane D on re-ace- 
tylation. The purified products identified as LNFP II 
and LNFP III are shown in lanes E and F, respectively. 
Preparative TLC of band IV gave a product contami- 
nated with LNFP II (lane G). A second preparative 
TLC step gave band 1V with no detectable contami- 
nant (not shown). 
After de-acetylation LNFP II, LNFP III and band 
1V had identical mobilities on TLC (fig.3 (B-D)). 
These pentasaccharides were clearly separable from 
the unfucosylated type 1- and type 2-based tetrasac- 
charides, lacto-N-tetraose (lane E) and lacto-N-neote- 
traose (lane F) respectively, which were partiaUy 
separable from each other. 
When the three purified lacto-N-fucopentaose 
isomers were tested in radioimmunoassays with anti- 
SSEA-1 only that identified as LNFP III had inhibitory 
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activity (rigA). This oligosaccharide was ~3-times less 
active than oligosaccharide N-1 R L 0.71 a. 
These studies clearly demonstrate he importance 
of separating closely related oligosaccharide isomers 
in determining the precise specificity of anti-carbo- 
hydrate antibodies. We have established that anti- 
SSEA-1, like conventional ntisera gainst LNFP III 
[9], is specific for the fucosylated type 2 sequence 
and that it does not cross-react with the type 1-based, 
Lea-active structure. Furthermore, the lower inhibitory 
activity of LNFP III compared with that of N-1 R L 
0.71 a raises the possibility that the combining site of 
anti-SSEA-1 is more complementary to the sequence: 
branched sequences are required to determine the 
complete antigenic determinant recognised by this 
antibody. 
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Gal/31 -+ 4GlcNAc/31 -~ 3 
1" 1,3 
Fuc~ 
The former sequence is presumably derived [3,10] 
from a branched structure such as the following: 
Fuca 
$ 1,3 
Gal/31 -~ 4GlcNAc/31 " " '~6 
Gal/31 -~ 3/4GlcNAc/31 ~'~'3Gal/31 
t 1,4/3 
Fuco~ 
and the latter is known to occur as part of  both linear 
and branched carbohydrate chains. Further studies 
with defined oligosaccharides containing internally 
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